Pulse Biosciences, Inc. (NASDAQ: PLSE) Q4 2024 Earnings Call Transcript March 27, 2025 Pulse Biosciences, Inc. beats earnings ...
This study provides compelling real-world evidence that statin use may significantly reduce the risk of both liver cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback